Elzovantinib blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases.
Molecular Weight
409.42
Molecular Formula
C20H20FN7O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Elzovantinib is studied for its potential to inhibit Src, providing a basis for cancer treatment research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
